Study S000004

The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04979611
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: NONE
Status: UNKNOWN
Enrollment: 60
Start: 2020-08-01
Primary completion: 2025-08-01
Lead sponsor: First Affiliated Hospital of Fujian Medical University
Conditions: Insulinoma
Interventions: DRUG:68Ga-NOTA-exendin-4
Results posted: FALSE

Registered primary outcomes

Standard uptake value (SUV) [From right after tracer injection to 1-hours post-injection]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.